Intrahepatic Cholangiocarcinoma Clinical Trials in Fuzhou, Fujian
3 recruitingFuzhou, Fujian, China
Showing 1–3 of 3 trials
Recruiting
D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital37 enrolled1 locationNCT06643208
Recruiting
Early Phase 1
Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection
Intrahepatic Cholangiocarcinoma
Yongyi Zeng10 enrolled1 locationNCT06406816
Recruiting
Phase 2
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Beijing InnoCare Pharma Tech Co., Ltd.70 enrolled44 locationsNCT05678270